Risk factor management in a contemporary Australian population at increased cardiovascular disease risk

Duncan J. Campbell, Jennifer M. Coller, Fei Fei Gong, Michele McGrady, David L. Prior, Umberto Boffa, Louise Shiel, Danny Liew, Rory Wolfe, Alice J. Owen, Henry Krum, Christopher M. Reid

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

Background: Effective management of cardiovascular and chronic kidney disease risk factors offers longer, healthier lives and savings in healthcare. Aim: To examine risk factor management in participants of the SCReening Evaluation of the Evolution of New Heart Failure study, a self-selected population at increased cardiovascular disease risk recruited from members of a health insurance fund in Melbourne and Shepparton, Australia. Methods: Inclusion criteria were age ≥ 60 years with one or more self-reported ischaemic or other heart diseases, irregular or rapid heart rhythm, cerebrovascular disease, renal impairment or treatment for hypertension or diabetes for ≥2 years. Exclusion criteria were known heart failure or cardiac abnormality on echocardiography or other imaging. Medical history, clinical examination, full blood examination and biochemistry (without lipids and glycated haemoglobin (HbA1c)) were performed for 3847 participants on enrolment, and blood pressure, lipids and HbA1c were measured 1–2 years after enrolment for 3203 participants. Results: Despite 99% of 3294 participants with hypertension receiving antihypertensive medication, half had blood pressures >140/90 mmHg. Approximately 77% of participants were overweight or obese, with one third being obese. Additionally, 74% of participants at high cardiovascular disease risk had low-density lipoprotein cholesterol levels ≥2 mmol/L, one third of diabetic participants had HbA1c >7%, 22% had an estimated glomerular filtration rate < 60 mL/min/1.73m2, and substantial proportions had under-utilisation of antiplatelet therapy and anticoagulation for atrial fibrillation and were physically inactive. Conclusions: This population demonstrated substantial potential to reduce cardiovascular and renal morbidity and mortality and healthcare costs through more effective management of modifiable risk factors.

Original languageEnglish
Pages (from-to)688-698
Number of pages11
JournalInternal Medicine Journal
Volume48
Issue number6
DOIs
Publication statusPublished - 1 Jun 2018

Keywords

  • blood pressure target
  • cardiovascular disease
  • chronic kidney disease
  • medication
  • population cohort
  • risk factors

Cite this

Campbell, Duncan J. ; Coller, Jennifer M. ; Gong, Fei Fei ; McGrady, Michele ; Prior, David L. ; Boffa, Umberto ; Shiel, Louise ; Liew, Danny ; Wolfe, Rory ; Owen, Alice J. ; Krum, Henry ; Reid, Christopher M. / Risk factor management in a contemporary Australian population at increased cardiovascular disease risk. In: Internal Medicine Journal. 2018 ; Vol. 48, No. 6. pp. 688-698.
@article{207e674a38694167b18d5e016ea717c3,
title = "Risk factor management in a contemporary Australian population at increased cardiovascular disease risk",
abstract = "Background: Effective management of cardiovascular and chronic kidney disease risk factors offers longer, healthier lives and savings in healthcare. Aim: To examine risk factor management in participants of the SCReening Evaluation of the Evolution of New Heart Failure study, a self-selected population at increased cardiovascular disease risk recruited from members of a health insurance fund in Melbourne and Shepparton, Australia. Methods: Inclusion criteria were age ≥ 60 years with one or more self-reported ischaemic or other heart diseases, irregular or rapid heart rhythm, cerebrovascular disease, renal impairment or treatment for hypertension or diabetes for ≥2 years. Exclusion criteria were known heart failure or cardiac abnormality on echocardiography or other imaging. Medical history, clinical examination, full blood examination and biochemistry (without lipids and glycated haemoglobin (HbA1c)) were performed for 3847 participants on enrolment, and blood pressure, lipids and HbA1c were measured 1–2 years after enrolment for 3203 participants. Results: Despite 99{\%} of 3294 participants with hypertension receiving antihypertensive medication, half had blood pressures >140/90 mmHg. Approximately 77{\%} of participants were overweight or obese, with one third being obese. Additionally, 74{\%} of participants at high cardiovascular disease risk had low-density lipoprotein cholesterol levels ≥2 mmol/L, one third of diabetic participants had HbA1c >7{\%}, 22{\%} had an estimated glomerular filtration rate < 60 mL/min/1.73m2, and substantial proportions had under-utilisation of antiplatelet therapy and anticoagulation for atrial fibrillation and were physically inactive. Conclusions: This population demonstrated substantial potential to reduce cardiovascular and renal morbidity and mortality and healthcare costs through more effective management of modifiable risk factors.",
keywords = "blood pressure target, cardiovascular disease, chronic kidney disease, medication, population cohort, risk factors",
author = "Campbell, {Duncan J.} and Coller, {Jennifer M.} and Gong, {Fei Fei} and Michele McGrady and Prior, {David L.} and Umberto Boffa and Louise Shiel and Danny Liew and Rory Wolfe and Owen, {Alice J.} and Henry Krum and Reid, {Christopher M.}",
year = "2018",
month = "6",
day = "1",
doi = "10.1111/imj.13678",
language = "English",
volume = "48",
pages = "688--698",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "6",

}

Risk factor management in a contemporary Australian population at increased cardiovascular disease risk. / Campbell, Duncan J.; Coller, Jennifer M.; Gong, Fei Fei; McGrady, Michele; Prior, David L.; Boffa, Umberto; Shiel, Louise; Liew, Danny; Wolfe, Rory; Owen, Alice J.; Krum, Henry; Reid, Christopher M.

In: Internal Medicine Journal, Vol. 48, No. 6, 01.06.2018, p. 688-698.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Risk factor management in a contemporary Australian population at increased cardiovascular disease risk

AU - Campbell, Duncan J.

AU - Coller, Jennifer M.

AU - Gong, Fei Fei

AU - McGrady, Michele

AU - Prior, David L.

AU - Boffa, Umberto

AU - Shiel, Louise

AU - Liew, Danny

AU - Wolfe, Rory

AU - Owen, Alice J.

AU - Krum, Henry

AU - Reid, Christopher M.

PY - 2018/6/1

Y1 - 2018/6/1

N2 - Background: Effective management of cardiovascular and chronic kidney disease risk factors offers longer, healthier lives and savings in healthcare. Aim: To examine risk factor management in participants of the SCReening Evaluation of the Evolution of New Heart Failure study, a self-selected population at increased cardiovascular disease risk recruited from members of a health insurance fund in Melbourne and Shepparton, Australia. Methods: Inclusion criteria were age ≥ 60 years with one or more self-reported ischaemic or other heart diseases, irregular or rapid heart rhythm, cerebrovascular disease, renal impairment or treatment for hypertension or diabetes for ≥2 years. Exclusion criteria were known heart failure or cardiac abnormality on echocardiography or other imaging. Medical history, clinical examination, full blood examination and biochemistry (without lipids and glycated haemoglobin (HbA1c)) were performed for 3847 participants on enrolment, and blood pressure, lipids and HbA1c were measured 1–2 years after enrolment for 3203 participants. Results: Despite 99% of 3294 participants with hypertension receiving antihypertensive medication, half had blood pressures >140/90 mmHg. Approximately 77% of participants were overweight or obese, with one third being obese. Additionally, 74% of participants at high cardiovascular disease risk had low-density lipoprotein cholesterol levels ≥2 mmol/L, one third of diabetic participants had HbA1c >7%, 22% had an estimated glomerular filtration rate < 60 mL/min/1.73m2, and substantial proportions had under-utilisation of antiplatelet therapy and anticoagulation for atrial fibrillation and were physically inactive. Conclusions: This population demonstrated substantial potential to reduce cardiovascular and renal morbidity and mortality and healthcare costs through more effective management of modifiable risk factors.

AB - Background: Effective management of cardiovascular and chronic kidney disease risk factors offers longer, healthier lives and savings in healthcare. Aim: To examine risk factor management in participants of the SCReening Evaluation of the Evolution of New Heart Failure study, a self-selected population at increased cardiovascular disease risk recruited from members of a health insurance fund in Melbourne and Shepparton, Australia. Methods: Inclusion criteria were age ≥ 60 years with one or more self-reported ischaemic or other heart diseases, irregular or rapid heart rhythm, cerebrovascular disease, renal impairment or treatment for hypertension or diabetes for ≥2 years. Exclusion criteria were known heart failure or cardiac abnormality on echocardiography or other imaging. Medical history, clinical examination, full blood examination and biochemistry (without lipids and glycated haemoglobin (HbA1c)) were performed for 3847 participants on enrolment, and blood pressure, lipids and HbA1c were measured 1–2 years after enrolment for 3203 participants. Results: Despite 99% of 3294 participants with hypertension receiving antihypertensive medication, half had blood pressures >140/90 mmHg. Approximately 77% of participants were overweight or obese, with one third being obese. Additionally, 74% of participants at high cardiovascular disease risk had low-density lipoprotein cholesterol levels ≥2 mmol/L, one third of diabetic participants had HbA1c >7%, 22% had an estimated glomerular filtration rate < 60 mL/min/1.73m2, and substantial proportions had under-utilisation of antiplatelet therapy and anticoagulation for atrial fibrillation and were physically inactive. Conclusions: This population demonstrated substantial potential to reduce cardiovascular and renal morbidity and mortality and healthcare costs through more effective management of modifiable risk factors.

KW - blood pressure target

KW - cardiovascular disease

KW - chronic kidney disease

KW - medication

KW - population cohort

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85048370050&partnerID=8YFLogxK

U2 - 10.1111/imj.13678

DO - 10.1111/imj.13678

M3 - Article

VL - 48

SP - 688

EP - 698

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 6

ER -